Sutro Biopharma Stock Price History

STRO Stock  USD 0.81  0.07  7.95%   
Below is the normalized historical share price chart for Sutro Biopharma extending back to September 27, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sutro Biopharma stands at 0.81, as last reported on the 2nd of August, with the highest price reaching 0.90 and the lowest price hitting 0.80 during the day.
IPO Date
27th of September 2018
200 Day MA
1.636
50 Day MA
0.8232
Beta
1.64
 
Covid
If you're considering investing in Sutro Stock, it is important to understand the factors that can impact its price. Sutro Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0488, which indicates the firm had a -0.0488 % return per unit of risk over the last 3 months. Sutro Biopharma exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sutro Biopharma's Coefficient Of Variation of 49575.02, semi deviation of 4.85, and Risk Adjusted Performance of 0.0103 to confirm the risk estimate we provide.
As of the 2nd of August 2025, Stock Based Compensation To Revenue is likely to grow to 0.42, while Total Stockholder Equity is likely to drop about 42.4 M. . At this time, Sutro Biopharma's Price To Sales Ratio is very stable compared to the past year. As of the 2nd of August 2025, Price Book Value Ratio is likely to grow to 3.33, though Price Earnings Ratio is likely to grow to (0.59). Sutro Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0488

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSTRO

Estimated Market Risk

 5.53
  actual daily
49
51% of assets are more volatile

Expected Return

 -0.27
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Sutro Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sutro Biopharma by adding Sutro Biopharma to a well-diversified portfolio.
Price Book
2.1114
Enterprise Value Ebitda
0.4055
Price Sales
1.0298
Shares Float
61.1 M
Wall Street Target Price
3.2571

Sutro Biopharma Stock Price History Chart

There are several ways to analyze Sutro Stock price data. The simplest method is using a basic Sutro candlestick price chart, which shows Sutro Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMay 7, 20250.99
Lowest PriceJuly 1, 20250.68

Sutro Biopharma August 2, 2025 Stock Price Synopsis

Various analyses of Sutro Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sutro Stock. It can be used to describe the percentage change in the price of Sutro Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sutro Stock.
Sutro Biopharma Price Rate Of Daily Change 0.92 
Sutro Biopharma Price Action Indicator(0.07)
Sutro Biopharma Price Daily Balance Of Power(0.70)

Sutro Biopharma August 2, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Sutro Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Sutro Biopharma intraday prices and daily technical indicators to check the level of noise trading in Sutro Stock and then apply it to test your longer-term investment strategies against Sutro.

Sutro Stock Price History Data

The price series of Sutro Biopharma for the period between Sun, May 4, 2025 and Sat, Aug 2, 2025 has a statistical range of 0.42 with a coefficient of variation of 10.1. The price distribution for the period has arithmetic mean of 0.85. The median price for the last 90 days is 0.84.
OpenHighLowCloseVolume
08/02/2025
 0.86  0.90  0.80  0.81 
08/01/2025
 0.80  0.85  0.80  0.81  233,544 
07/31/2025
 0.86  0.90  0.80  0.81  279,924 
07/30/2025
 0.83  0.91  0.83  0.88  377,107 
07/29/2025
 0.88  0.90  0.83  0.84  361,716 
07/28/2025
 0.89  0.92  0.85  0.85  576,612 
07/25/2025
 0.93  0.96  0.87  0.89  362,142 
07/24/2025
 0.87  1.01  0.87  0.92  1,405,901 
07/23/2025 0.86  0.88  0.84  0.86  407,077 
07/22/2025 0.81  0.88  0.81  0.86  932,959 
07/21/2025
 0.76  0.90  0.76  0.80  1,322,073 
07/18/2025
 0.77  0.80  0.76  0.76  205,763 
07/17/2025
 0.78  0.83  0.77  0.77  500,413 
07/16/2025
 0.75  0.77  0.75  0.76  282,280 
07/15/2025
 0.75  0.79  0.74  0.75  446,254 
07/14/2025
 0.76  0.80  0.75  0.76  374,847 
07/11/2025
 0.81  0.83  0.76  0.76  229,298 
07/10/2025
 0.78  0.83  0.78  0.82  283,064 
07/09/2025
 0.78  0.83  0.78  0.79  227,899 
07/08/2025
 0.75  0.79  0.74  0.78  370,710 
07/07/2025
 0.76  0.78  0.73  0.74  720,670 
07/03/2025
 0.76  0.78  0.75  0.76  141,879 
07/02/2025
 0.69  0.79  0.69  0.76  970,278 
07/01/2025
 0.72  0.73  0.67  0.68  1,100,666 
06/30/2025 0.74  0.77  0.71  0.71  752,239 
06/27/2025
 0.80  0.81  0.73  0.73  11,763,555 
06/26/2025
 0.80  0.84  0.77  0.80  1,130,065 
06/25/2025
 0.81  0.87  0.79  0.81  811,251 
06/24/2025
 0.80  0.84  0.80  0.82  383,339 
06/23/2025
 0.80  0.84  0.76  0.80  657,355 
06/20/2025
 0.82  0.84  0.80  0.80  629,391 
06/18/2025
 0.80  0.84  0.76  0.79  719,589 
06/17/2025
 0.88  0.90  0.78  0.79  888,011 
06/16/2025 0.87  0.94  0.80  0.88  1,113,562 
06/13/2025
 0.82  0.82  0.76  0.80  700,324 
06/12/2025
 0.84  0.84  0.78  0.81  870,437 
06/11/2025
 0.82  0.85  0.80  0.83  1,168,890 
06/10/2025 0.84  0.88  0.82  0.84  1,438,005 
06/09/2025
 0.85  0.86  0.80  0.83  838,460 
06/06/2025 0.83  0.88  0.82  0.85  632,005 
06/05/2025
 0.92  0.93  0.82  0.82  1,418,557 
06/04/2025
 0.90  0.95  0.89  0.91  517,248 
06/03/2025
 0.90  0.95  0.87  0.91  764,943 
06/02/2025 0.88  0.92  0.87  0.90  609,291 
05/30/2025
 0.89  0.91  0.86  0.90  528,290 
05/29/2025
 0.90  0.92  0.88  0.90  616,771 
05/28/2025 0.93  0.96  0.90  0.92  667,837 
05/27/2025
 0.88  0.96  0.88  0.94  1,044,410 
05/23/2025
 0.87  0.92  0.85  0.92  721,587 
05/22/2025
 0.83  0.92  0.83  0.90  789,905 
05/21/2025
 0.87  0.90  0.83  0.84  711,317 
05/20/2025
 0.87  0.90  0.82  0.90  675,841 
05/19/2025 0.91  0.99  0.85  0.88  783,141 
05/16/2025
 0.88  0.94  0.85  0.91  1,195,144 
05/15/2025 0.74  0.89  0.72  0.88  1,749,699 
05/14/2025
 0.82  0.83  0.72  0.73  1,360,182 
05/13/2025
 0.85  0.91  0.81  0.82  1,160,595 
05/12/2025
 0.89  1.00  0.86  0.87  1,669,463 
05/09/2025
 1.00  1.00  0.87  0.87  1,051,368 
05/08/2025
 1.00  1.00  0.89  0.96  2,219,474 
05/07/2025
 0.94  1.00  0.93  0.99  2,362,954 

About Sutro Biopharma Stock history

Sutro Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sutro is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sutro Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sutro Biopharma stock prices may prove useful in developing a viable investing in Sutro Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding76.8 M39.1 M
Net Loss-107.3 M-101.9 M

Sutro Biopharma Quarterly Net Working Capital

154.36 Million

Sutro Biopharma Stock Technical Analysis

Sutro Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sutro Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sutro Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Sutro Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Sutro Biopharma's price direction in advance. Along with the technical and fundamental analysis of Sutro Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sutro to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Sutro Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sutro Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sutro Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sutro Biopharma Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.92)
Revenue Per Share
0.808
Quarterly Revenue Growth
0.338
Return On Assets
(0.40)
Return On Equity
(6.79)
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.